Spark Plus Singapore Healthcare Day Presentation
Arovella is pleased to announce that its CEO and MD, Dr Michael Baker, will today 14 March 2024, present at the Spark Plus Singapore Healthcare Day. Dr Baker will present key pre-clinical data for Arovella’s iNKT cell therapy platform and described how Arovella’s technology provides important advantages over existing T-cell therapies and has the potential to be applied to both blood cancers and solid tumours. The presentation can be viewed below.
